## KKR: KKR & Co. Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.58 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($123.54)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Mizuho Financial Group buys out KKR, takes charge of Avendus**
- Source: The Economic Times | 20251217T090928 | Bullish | Relevance: 100%
- Mizuho Financial Group has acquired a controlling stake in Indian investment bank Avendus, allowing KKR to exit its nine-year-old investment. The deal values Avendus at ₹5,900 crore, translating to a 3.5x return for KKR. Avendus's co-founders Gaurav Deepak and Kaushal Aggarwal will retain operational control.

**2. KKR Invests $220M in Premialab for Global Expansion**
- Source: GuruFocus | 20251216T110013 | Somewhat-Bearish | Relevance: 100%
- KKR has invested $220 million in Premialab, a data and analytics company for quantitative investing, to accelerate its international growth. This investment comes as KKR, a leading alternative asset manager, faces concerns regarding declining revenue growth and profitability margins. Despite a strong balance sheet liquidity, KKR's financial health is under scrutiny due to a high debt-to-equity ratio and an Altman Z-Score in the distress zone.

**3. KKR (NYSE: KKR) puts $220m into Premialab in first Gulf deal for NGT fund**
- Source: Stock Titan | 20251216T083314 | Bullish | Relevance: 100%
- KKR has invested $220 million in Premialab, a global provider of data, analytics, and risk management solutions for quantitative investing. This strategic investment, made through KKR's Next Generation Technology Growth Fund III, marks the fund's first deal in the Gulf region. The capital will support Premialab's global expansion, operational system development, and the scaling of its newly launched execution product with Eurex, aiming to enhance its position as a market standard for Quantitative Investment Strategies (QIS).

**4. KKR nears sale of Viridor stake to Equitix - report**
- Source: MSN | 20251217T151500 | Neutral | Relevance: 100%
- KKR is reportedly close to selling its stake in Viridor, a waste management company, to infrastructure fund Equitix. This potential deal follows KKR's acquisition of Viridor in 2020 for an enterprise value of £4.2 billion.

**5. Northside Capital Management LLC Decreases Stock Holdings in KKR & Co. Inc. $KKR**
- Source: MarketBeat | 20251217T130608 | Neutral | Relevance: 100%
- Northside Capital Management LLC reduced its stake in KKR & Co. Inc. by 24.1% in the third quarter, selling 11,325 shares to hold 35,743 shares valued at $4,645,000. KKR outperformed quarterly estimates with EPS of $1.41 and revenue of $4.36 billion, maintaining a "Moderate Buy" analyst consensus with a target price of $158.79. The company also declared a quarterly dividend of $0.185 per share, representing an annualized yield of 0.6%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $169 | $154 | +10% |
| 2025-12-11 | UBS | $176 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-11 | UBS | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($5.74M) |
| Sells | 2 ($424.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 6.7% (+1.0%)
- Blackrock Inc.: 5.4% (-1.1%)
- Capital Internationa: 3.5% (-1.4%)
- State Street Corpora: 3.1% (+1.6%)
- Wellington Managemen: 2.7% (+1.3%)

### Key Risks

1. High beta (2.00) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $424M sold (2 transactions in 90 days).
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.58 indicates undervaluation relative to growth. Forward P/E 19.4x attractive for 32% earnings growth. Balance sheet: strong liquidity (4.2x), $2.4B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment positive (1 raises, avg +10%). Insider selling cluster ($424.4M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $122.2B |
| Beta | 2.00 |
| 52W Range | $86.15 - $170.40 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.58 |
| Forward P/E | 19.4 |
| Current P/E | 25.7 |
| YoY Growth | 32.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 9.1% to 3.8% (-5.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.2pp (needs >4.0% for momentum thesis). MRS_5 (-1.3%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.0% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.82% (CS: 76) | Neutral |
| RSI_14 | 56.4 | Neutral |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 1.030x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 1.042x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $132.06
- **Stop Loss:** $123.54 (6.5% risk)
- **Target:** $149.10 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 83
- **Position Value:** $10,960.98
- **Portfolio %:** 10.96%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-06 (Est: $1.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.41 | +8.6% |
| 2025Q2 | $1.14 | $1.18 | +3.6% |
| 2025Q1 | $1.13 | $1.15 | +1.7% |
| 2024Q4 | $1.28 | $1.32 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*